Commonwealth of Pennsylvania Public School Empls Retrmt SYS decreased its position in shares of DaVita Inc. (NYSE:DVA – Free Report) by 4.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,590 shares of the company’s stock after selling 455 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in DaVita were worth $1,434,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also made changes to their positions in DVA. SBI Securities Co. Ltd. acquired a new position in DaVita during the fourth quarter worth approximately $41,000. Quarry LP acquired a new position in shares of DaVita in the 3rd quarter valued at $60,000. Venturi Wealth Management LLC raised its position in DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after purchasing an additional 152 shares during the last quarter. Versant Capital Management Inc boosted its stake in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after purchasing an additional 169 shares during the period. Finally, Blue Trust Inc. grew its position in DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after purchasing an additional 131 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.
DaVita Stock Up 0.1 %
DVA opened at $150.60 on Wednesday. The business has a 50 day simple moving average of $158.18 and a 200-day simple moving average of $157.57. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The stock has a market capitalization of $12.05 billion, a P/E ratio of 14.02, a P/E/G ratio of 1.07 and a beta of 0.99. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21.
Analyst Ratings Changes
A number of equities research analysts have recently commented on DVA shares. Cowen reaffirmed a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on DaVita in a research report on Friday, February 21st. StockNews.com downgraded DaVita from a “buy” rating to a “hold” rating in a research note on Friday, March 21st. Finally, Barclays increased their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $166.33.
Read Our Latest Stock Analysis on DVA
DaVita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading
- Five stocks we like better than DaVita
- What Are the U.K. Market Holidays? How to Invest and Trade
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- What Are Dividend Contenders? Investing in Dividend Contenders
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.